OBRENZA 150MG TABLET

Form: Tablets

Pack Size: 60 TABLETS

Marketed by: SUN PHARMA LABORATORIES LTD (ONCOLOGY DIV)

MRP: ₹18840.20

SUN PHARMA LABORATORIES LTD (ONCOLOGY DIV): Obrenza 150MG Tablet, 60 tablets, salt olaparib 150mg. NPPA has revised its MRP from Rs 23,906.25 to Rs 18,840.20 (21% lower) with effect from 09-11-2026; trade rate Rs 14,354.44. Group: PARP inhibitor (targeted therapy). Same salt is also supplied by Abbott, AstraZeneca, Cipla, Dr. Reddy's, Emcure and others. Handling/counselling: tablet and capsule forms are not interchangeable mg for mg; check the prescription carefully. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.